Eastwood Bio-Medical Canada Inc.

TSXV:EBM Stock Report

Market Cap: CA$31.0m

Eastwood Bio-Medical Canada Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Youngsoo Kim

Chief executive officer

CA$31.3k

Total compensation

CEO salary percentage100.0%
CEO tenure4.3yrs
CEO ownership0.2%
Management average tenureno data
Board average tenure11.5yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Youngsoo Kim's remuneration changed compared to Eastwood Bio-Medical Canada's earnings?
DateTotal CompensationSalaryCompany Earnings
Jul 31 2024n/an/a

-CA$484k

Apr 30 2024n/an/a

-CA$486k

Jan 31 2024n/an/a

-CA$532k

Oct 31 2023CA$31kCA$31k

-CA$547k

Jul 31 2023n/an/a

-CA$387k

Apr 30 2023n/an/a

-CA$355k

Jan 31 2023n/an/a

-CA$209k

Oct 31 2022CA$29kCA$29k

-CA$150k

Jul 31 2022n/an/a

-CA$130k

Apr 30 2022n/an/a

-CA$221k

Jan 31 2022n/an/a

-CA$422k

Oct 31 2021CA$29kCA$29k

-CA$604k

Jul 31 2021n/an/a

-CA$874k

Apr 30 2021n/an/a

-CA$772k

Jan 31 2021n/an/a

-CA$800k

Oct 31 2020CA$5kCA$5k

-CA$852k

Compensation vs Market: Youngsoo's total compensation ($USD21.74K) is below average for companies of similar size in the Canadian market ($USD164.38K).

Compensation vs Earnings: Youngsoo's compensation has increased whilst the company is unprofitable.

CEO

Youngsoo Kim

4.3yrs

Tenure

CA$31,253

Compensation

Dr. Youngsoo Kim serves as Chief Executive Officer of Eastwood Bio-Medical Canada Inc. since September 1, 2020 and is its Founder. He serves as the Chief Executive Officer and Owner of Eastwood Bio-Medical...

Board Members

NamePositionTenureCompensationOwnership
Youngsoo Kim
Founder4.4yrsCA$31.25k0.16%
CA$ 50.4k
Yunji Kim
President12.3yrsCA$36.07k0.018%
CA$ 5.5k
Terrance Owen
Independent Director11.5yrsno datano data
Ian Mallmann
Independent Director5.5yrsCA$4.00kno data
Marcus Kuypers
Independent Director11.5yrsno data0.0058%
CA$ 1.8k

11.5yrs

Average Tenure

66yo

Average Age

Experienced Board: EBM's board of directors are seasoned and experienced ( 11.5 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/24 07:27
End of Day Share Price 2025/01/20 00:00
Earnings2024/07/31
Annual Earnings2023/10/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Eastwood Bio-Medical Canada Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution